Accuray reported $34.6M in Gross Profit on Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbott ABT:US USD 5.78B 543M
Accuray ARAY:US USD 34.6M 8.42M
Atricure ATRC:US USD 61.71M 1.81M
Boston Scientific BSX:US USD 2.18B 42M
Cardiovascular Systems CSII:US USD 42.98M 3.25M
Cryolife CRY:US USD 48.74M 3.43M
Edwards Lifesciences EW:US USD 1.07B 37.7M
Hologic HOLX:US USD 522.9M 36.1M
Mesa Laboratories MLAB:US USD 36.39M 5.04M
Tandem Diabetes Care TNDM:US USD 104.42M 2.48M